2024 ASCO® Annual Meeting Insights Hub

Meeting coverage & Vumedi’s exclusive highlights, all in one place.

 

ASCO® 2024 Insights: "Individualized Neoantigen Therapy mRNA-4157 (V940) + Pembro in Resected Melanoma"

31 views
June 11, 2024
0 Comments
Login to view comments. Click here to Login